Published in J Cardiovasc Pharmacol on September 01, 2000
Perioperative hypertension management. Vasc Health Risk Manag (2008) 1.13
Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis. Blood Press Suppl (2010) 0.79
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
[Acute coronary syndromes. Simplified routines with early exercise test performed at the intensive coronary care units]. Lakartidningen (1993) 3.19
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J (2004) 2.80
A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation (1982) 2.22
Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation (1997) 2.13
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Ann Oncol (2012) 2.02
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Eur J Surg Oncol (2013) 1.99
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J (1996) 1.83
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care (1999) 1.72
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur Heart J (2000) 1.60
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol (1991) 1.52
Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol (1994) 1.46
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ (1994) 1.46
Social relations and extent and severity of coronary artery disease. The Stockholm Female Coronary Risk Study. Eur Heart J (1998) 1.45
Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia (2005) 1.44
Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J (2002) 1.42
Phenformin and pulmonary hypertension. Br Heart J (1973) 1.40
A new apparatus for detection of impending pacemaker failure in patients treated with implanted pacemakers. Cardiovasc Res (1970) 1.39
Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein. J Biol Chem (1978) 1.37
Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37
Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry (1976) 1.36
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36
A rapid and specific method for isolation of thiol-containing peptides from large proteins by thiol-disulfide exchange on a solid support. Proc Natl Acad Sci U S A (1975) 1.33
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. Eur Heart J (2000) 1.31
Re-used pacemakers--as safe as new? A retrospective case-control study. Eur Heart J (1998) 1.31
Myocardial infarction in patients with diabetes mellitus. Eur Heart J (1988) 1.30
Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. Eur Heart J (1999) 1.28
Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur J Anaesthesiol (2003) 1.27
Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis. J Intern Med (1989) 1.26
Mode of death in heart failure: findings from the ATLAS trial. Heart (2003) 1.24
Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study. Eur Heart J (1999) 1.23
Quality-of-life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: a long-term, double-blind, crossover study. Pacing Clin Electrophysiol (1992) 1.21
Aortic valve replacement in octogenarians with aortic stenosis: a case-control study. J Am Coll Cardiol (1992) 1.18
Physiological versus single-rate ventricular pacing: a double-blind cross-over study. Pacing Clin Electrophysiol (1985) 1.16
Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand (1988) 1.15
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. J Am Coll Cardiol (2000) 1.15
Single-chain structure of human ceruloplasmin. Eur J Biochem (1972) 1.14
The effect of ventricular activation sequence on cardiac performance during pacing. Pacing Clin Electrophysiol (1996) 1.14
Comparison of physical work capacity and systolic time intervals with ventricular inhibited and atrial synchronous ventricular inhibited pacing. Br Heart J (1981) 1.14
Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart (2004) 1.12
Molecular weight of beef heart aconitase and stoichiometry of the components of its iron-sulfur cluster. J Biol Chem (1984) 1.12
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J (2001) 1.12
Isolation and properties of a staphylococcal protease, preferentially cleaving glutamoyl-peptide bonds. Eur J Biochem (1974) 1.12
Causes of more frequent deletions than insertions in mutations and protein evolution. Nature (1981) 1.10
Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clin Pharmacol Ther (1980) 1.10
Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J (1999) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. Eur J Pharmacol (1985) 1.07
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial. J Clin Pathol (2005) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol (1999) 1.06
Sustained effect of hydralazine in long term treatment of CHF. Acta Med Scand Suppl (1981) 1.05
Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol (1995) 1.04
Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents. Acta Med Scand (1981) 1.01
The amino-acid sequences of three tryptic glycopeptides from human ceruloplasmin. Eur J Biochem (1974) 1.01
Effect of lignocaine on heart rate in patients with sinus bradycardia associated with proven or suspected acute myocardial infarction. Cardiovasc Res (1972) 1.01
Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats. Drugs (1985) 1.01
Clinical and electrophysiological characteristics of a transvenous atrial lead. Br Heart J (1979) 1.00
Reduction of hospital days by biventricular pacing. Eur J Heart Fail (2000) 0.99
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res (1997) 0.98
The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation (1983) 0.98
A model of the three-dimensional structure of snake venom neurotoxins based on chemical evidence. Int J Pept Protein Res (1973) 0.97
Longevity in patients with high degree atrioventricular block paced in the atrial synchronous or the fixed rate ventricular inhibited mode. Pacing Clin Electrophysiol (1992) 0.96
Calcium antagonists, appropriate therapy for diabetic patients with hypertension? Eur Heart J (1998) 0.96
The Skaraborg hypertension project. I. The prevalence of hypertension. Acta Med Scand (1986) 0.96
Covalent chromatography as a means of isolating thiol peptides from large proteins: application to human ceruloplasmin. J Chromatogr (1981) 0.95
The Skaraborg hypertension project. III. Influence on blood pressure of a medical care program for hypertension. Acta Med Scand (1986) 0.95
Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand (1988) 0.95
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med (2004) 0.94
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med (2001) 0.94
Atrial synchronous ventricular pacing in ischaemic heart disease. Eur Heart J (1983) 0.93
Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. J Am Coll Cardiol (1990) 0.93
Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res (1997) 0.92
Reduced stroke incidence with structured hypertension care: the Skaraborg Hypertension Project. J Hypertens (1990) 0.92
Syncope caused by lithium treatment. Report on two cases and a prospective investigation of the prevalence of lithium-induced sinus node dysfunction. Acta Med Scand (1979) 0.92
Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg (2001) 0.92
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol (1999) 0.92
The haemodynamic importance of atrioventricular synchrony and rate increase at rest and during exercise. Eur Heart J (1985) 0.91
Model of the active site in the blue oxidases based on the ceruloplasmin-plastocyanin homology. Proc Natl Acad Sci U S A (1982) 0.91
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost (1998) 0.91
The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Diabetologia (2011) 0.91
AIB1 is a predictive factor for tamoxifen response in premenopausal women. Ann Oncol (2009) 0.91
Purification of a presynaptic neurotoxin from the venom of the australian tiger snake Notechis scutatus scutatus. Toxicon (1972) 0.90
Distribution of the collateral blood flow at the lateral border of the ischemic myocardium after acute coronary occlusion in the pig and the dog. Basic Res Cardiol (1984) 0.90
Effects of recombinant human extracellular-superoxide dismutase type C on myocardial infarct size in pigs. Free Radic Biol Med (1992) 0.90
Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol (1999) 0.90
Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care (2010) 0.90
Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology (2000) 0.89